Noradrenaline-induced cation currents in isolated rat paratracheal ganglion neurons.
The actions of noradrenaline (NA) on the neurons acutely isolated from paratracheal ganglia of rats and the ionic mechanisms involved were studied with nystatin-perforated patch recording configuration. Under current-clamp conditions, application of 10 microM NA produced membrane depolarization followed by repetitive action potentials. NA evoked an inward cationic current under voltage-clamp conditions at a holding potential of -60 mV. Transient tail inward ('hump') current was also induced by washout of NA. The NA-induced current was reduced by extracellular Ca(2+) and Mg(2+), with half-maximal concentrations of 0.7 and 2.6 mM for Ca(2+) and Mg(2+), respectively. Phenylephrine, an alpha(1)-adrenoceptor agonist, mimicked the NA-induced current, but the 'hump' current did not occur upon washout of phenylephrine. The NA-induced current was inhibited by prazosin and WB-4101, alpha(1)-adrenoceptor antagonists. In contrast, in the presence of yohimbine, an alpha(2)-adrenoceptor antagonist, the NA-induced current was potentiated and the washout of NA failed to evoke the 'hump' current. The pretreatment of paratracheal neurons with pertussis toxin also potentiated the NA-induced current. The NA-induced inward current was inhibited by pretreatment with U73122, a phospholipase C inhibitor, and xestospongin-C, a membrane-permeable IP(3) receptor antagonist. On the other hand, thapsigargin, BAPTA-AM and calmidazolium had no effect on the NA-induced current, suggesting that release of Ca(2+) from intracellular Ca(2+) stores via IP(3) receptors is not involved in the NA action. The cationic channels activated by NA play an important physiological role in neuronal membrane depolarization in rat paratracheal ganglia.
Umezu
Mari
M
Department of Cellular and System Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Ishibashi
Hitoshi
H
Umebayashi
Chisato
C
Akaike
Norio
N
Ito
Yushi
Y
D000322:Adrenergic Agonists / Q000494:pharmacology; D018674:Adrenergic Antagonists / Q000494:pharmacology; D000818:Animals; D002412:Cations; D004305:Dose-Response Relationship, Drug; D005726:Ganglia, Parasympathetic / Q000187:drug effects* / Q000502:physiology; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D014132:Trachea / Q000187:drug effects* / Q000502:physiology
D000322:Adrenergic Agonists; D018674:Adrenergic Antagonists; D002412:Cations; D009638:Norepinephrine